David Nicholson - Gilde Healthcare

team
Venture&Growth

All team members
David Nicholson
Operational Partner
United States of America

David Nicholson

Operational Partner

David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a division at Bayer; Vice President of Licensing and Knowledge Management at Merck; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, Research & Development and was a member of the company’s Executive Management Committee. He received a B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

Joep Muijrers

General Partner Public Investments
Venture&Growth
Joep Muijrers joined Gilde in 2021 with two decades of broad experience in life sciences, including senior roles in portfolio management, company operations and investment banking. Most recently, he served as Chief Financial Officer and...

Chris Allen

Associate HealthTech
Venture&Growth
Chris joined Gilde Healthcare in 2023 focusing on HealthTech investments. Prior to joining Gilde Chris worked as a medical doctor, training at St Mary's, London. Upon completion of training alongside clinical work, he led the...

Tristan Maguet

Senior Associate Therapeutics
Venture&Growth
Tristan Maguet joined Gilde in 2022 and focuses on the Therapeutics sector. He is involved in deal sourcing, due diligence and portfolio management. Prior to joining Gilde, Tristan was an Investment Analyst at a Mutual Fund...